BSEInsider Trading / SAST9h ago · 25 Sept 2026, 09:45 am

Pls find enclosed herewith closure of trading window intimation

Ajanta Pharma Ltd · 532331

✦ AI Summary

Ajanta Pharma Ltd has announced the closure of its trading window for dealing in securities from October 1, 2026, until 48 hours after the declaration of its second-quarter and half-year financial results for the period ended September 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ajanta Pharma Ltd - 532331 - Closure of Trading Window

Attachments (1)

📄

4acf7af1-c585-41c6-9497-d902885daea6.pdf

pdf

Download →
View document text
Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai 400 093, India W www.ajantapharma.com 25th September 2026 BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/l, Dalal Street, G block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: BSE - AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ Re: Closure of Trading Window Dear Sir/Madam, Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and “Ajanta’s Code of Conduct for Insiders”, the Trading Window for dealing in securities of the Company shall remain closed from Thursday, 1st October 2026 till 48 hours after the declaration of Financial Results of the Company for the second quarter and half year ended 30th September 2026. Kindly take the above information on record. Thanking you, Yours faithfully, Gaurang Shah Sr. VP- Legal & Company Secretary Corporate Identity Number - L24230MH1979PLC022059